95.52 USD
↘ 0.98 (1.02%)LIVE (AS OF 11:36 AM EST)
Halozyme Therapeutics, Inc. (HALO) is currently trading at $95.52. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Key drivers include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. HALO is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Nov 16, 2026.